产品简要
公司名称 :
赛默飞世尔
其他品牌 :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
产品类型 :
抗体
产品名称 :
雌激素受体α单克隆抗体(Sp1转录因子)
目录 :
MA1-39539
规格 :
7毫升
价格 :
美国349.00
克隆性 :
单克隆
宿主 :
共轭标签 :
nonconjugated
克隆名称 :
Sp1转录因子
反应物种 :
人乳头状瘤病毒, 人类, 小鼠, 大鼠,
应用 :
免疫印迹, 免疫组化, 免疫细胞化学, 免疫沉淀, 流式细胞仪, 免疫组化-石蜡切片, reverse phase protein lysate microarray, 其他
更多信息或购买 :
文章摘录数: 312
出版应用/物种/样品/稀释参考文献
  • 其他; 人类; 图 4c
Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed 出版商
  • 免疫印迹; 人类; 1:10; 图 2a
Sinkala E, Sollier Christen E, Renier C, Rosàs Canyelles E, Che J, Heirich K, et al. Profiling protein expression in circulating tumour cells using microfluidic western blotting. Nat Commun. 2017;8:14622 pubmed 出版商
  • reverse phase protein lysate microarray; 人类; 图 7a
Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed 出版商
  • reverse phase protein lysate microarray; 人类; 图 3a
. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543:378-384 pubmed 出版商
  • 流式细胞仪; 人类; 1:50; 图 ED7c
  • 免疫沉淀; 人类
  • 免疫印迹; 人类; 1:500; 图 2c, 4b, 4e,ED4b
Britschgi A, Duss S, Kim S, Couto J, Brinkhaus H, Koren S, et al. The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ER?. Nature. 2017;541:541-545 pubmed 出版商
  • 免疫印迹; 人类
Hill S, Nesser N, Johnson Camacho K, Jeffress M, Johnson A, Boniface C, et al. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling. Cell Syst. 2017;4:73-83.e10 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 图 st1
Nielsen T, Jensen M, Burugu S, Gao D, Jørgensen C, Balslev E, et al. High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial. Clin Cancer Res. 2017;23:946-953 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 表 2
Petrovic N, Davidovic R, Jovanovic Cupic S, Krajnovic M, Lukic S, Petrovic M, et al. Changes in miR-221/222 Levels in Invasive and In Situ Carcinomas of the Breast: Differences in Association with Estrogen Receptor and TIMP3 Expression Levels. Mol Diagn Ther. 2016;20:603-615 pubmed
  • 免疫印迹; 人类; 图 2
Trapé A, Liu S, Cortés A, Ueno N, Gonzalez Angulo A. Effects of CDK4/6 Inhibition in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Cells with Acquired Resistance to Paclitaxel. J Cancer. 2016;7:947-56 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:50; 图 s2
Carbognin L, Sperduti I, Brunelli M, Marcolini L, Nortilli R, Pilotto S, et al. Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer. J Exp Clin Cancer Res. 2016;35:50 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:100; 图 s1
Koussounadis A, Langdon S, Um I, Kay C, Francis K, Harrison D, et al. Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models. BMC Cancer. 2016;16:205 pubmed 出版商
  • 免疫组化; 人类; 1:100
Matsumoto H, Thike A, Li H, Yeong J, Koo S, Dent R, et al. Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer. Breast Cancer Res Treat. 2016;156:237-47 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:100
Kim S, Kim E, Lee H, Kim M, Yoon J, Koo J, et al. Asymptomatic Benign Papilloma Without Atypia Diagnosed at Ultrasonography-Guided 14-Gauge Core Needle Biopsy: Which Subgroup can be Managed by Observation?. Ann Surg Oncol. 2016;23:1860-6 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:100; 表 1
El Gendi S, Mostafa M. Runx2 Expression as a Potential Prognostic Marker in Invasive Ductal Breast Carcinoma. Pathol Oncol Res. 2016;22:461-70 pubmed 出版商
  • 免疫组化-石蜡切片; 人类
O Shaughnessy J, Campone M, Brain E, Neven P, Hayes D, Bondarenko I, et al. Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer. Ann Oncol. 2016;27:106-13 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:100
Eom K, Jang M, Park S, Kang E, Kim S, Kim J, et al. The Expression of Carbonic Anhydrase (CA) IX/XII and Lymph Node Metastasis in Early Breast Cancer. Cancer Res Treat. 2016;48:125-32 pubmed 出版商
  • 免疫细胞化学; 人类; 1:10; 图 s13b
Fridriksdottir A, Kim J, Villadsen R, Klitgaard M, Hopkinson B, Petersen O, et al. Propagation of oestrogen receptor-positive and oestrogen-responsive normal human breast cells in culture. Nat Commun. 2015;6:8786 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:100; 图 2
Jung Y, Kim H, Koo J. Expression of Lipid Metabolism-Related Proteins in Metastatic Breast Cancer. PLoS ONE. 2015;10:e0137204 pubmed 出版商
  • 免疫组化-石蜡切片; 人类
Coelho R, Calaça I, Celestrini D, Correia Carneiro A, Costa M, Zancan P, et al. Hexokinase and phosphofructokinase activity and intracellular distribution correlate with aggressiveness and invasiveness of human breast carcinoma. Oncotarget. 2015;6:29375-87 pubmed 出版商
  • 免疫组化; 人类
Gómez R, Ossa C, Montoya M, Echeverri C, Ángel G, Ascuntar J, et al. Impact of immunohistochemistry-based molecular subtype on chemosensitivity and survival in Hispanic breast cancer patients following neoadjuvant chemotherapy. Ecancermedicalscience. 2015;9:562 pubmed 出版商
  • 免疫组化; 人类; 1:100
KapucuoÄŸlu N, Bozkurt K, BaÅŸpınar Å, Koçer M, EroÄŸlu H, Akdeniz R, et al. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer. Pathol Res Pract. 2015;211:740-7 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:60
McBryan J, Fagan A, McCartan D, Bane F, VareÅ¡lija D, Cocchiglia S, et al. Transcriptomic Profiling of Sequential Tumors from Breast Cancer Patients Provides a Global View of Metastatic Expression Changes Following Endocrine Therapy. Clin Cancer Res. 2015;21:5371-9 pubmed 出版商
  • 免疫印迹; 人类; 图 2
Felzen V, Hiebel C, Koziollek Drechsler I, Reißig S, Wolfrum U, Kögel D, et al. Estrogen receptor α regulates non-canonical autophagy that provides stress resistance to neuroblastoma and breast cancer cells and involves BAG3 function. Cell Death Dis. 2015;6:e1812 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:25; 图 1c
Kawai M, Nakashima A, Kamada S, Kikkawa U. Midostaurin preferentially attenuates proliferation of triple-negative breast cancer cell lines through inhibition of Aurora kinase family. J Biomed Sci. 2015;22:48 pubmed 出版商
  • 免疫组化; 人类; 1:500
Mundim F, Pasini F, Brentani M, Soares F, Nonogaki S, Waitzberg A. MYC is expressed in the stromal and epithelial cells of primary breast carcinoma and paired nodal metastases. Mol Clin Oncol. 2015;3:506-514 pubmed
  • 免疫组化-石蜡切片; 人类; 1:50; 表 2
Cheung S, Boey Y, Koh V, Thike A, Lim J, Iqbal J, et al. Role of epithelial-mesenchymal transition markers in triple-negative breast cancer. Breast Cancer Res Treat. 2015;152:489-98 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:50
Koh V, Lim J, Thike A, Cheok P, Thu M, Tan V, et al. Characteristics and behaviour of screen-detected ductal carcinoma in situ of the breast: comparison with symptomatic patients. Breast Cancer Res Treat. 2015;152:293-304 pubmed 出版商
  • 免疫组化; 人类; 1:500
de Deus Moura R, Carvalho F, Bacchi C. Breast cancer in very young women: Clinicopathological study of 149 patients ≤25 years old. Breast. 2015;24:461-7 pubmed 出版商
  • 免疫组化-石蜡切片; 人类
Nwafor C, Keshinro S. Pattern of hormone receptors and human epidermal growth factor receptor 2 status in sub-Saharan breast cancer cases: Private practice experience. Niger J Clin Pract. 2015;18:553-8 pubmed 出版商
  • 免疫细胞化学; 人类; 1:50
Frithiof H, Welinder C, Larsson A, Rydén L, Aaltonen K. A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation. J Transl Med. 2015;13:126 pubmed 出版商
  • 免疫组化; 人类; 1:80
Geels Y, van der Putten L, van Tilborg A, Lurkin I, Zwarthoff E, Pijnenborg J, et al. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium. Gynecol Oncol. 2015;137:245-51 pubmed 出版商
  • 免疫组化-石蜡切片; 人类
Rusz O, Vörös A, Varga Z, Kelemen G, Uhercsák G, Nikolényi A, et al. One-Year Neoadjuvant Endocrine Therapy in Breast Cancer. Pathol Oncol Res. 2015;21:977-84 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:100; 表 4
Kim S, Lee Y, Koo J. Differential expression of lipid metabolism-related proteins in different breast cancer subtypes. PLoS ONE. 2015;10:e0119473 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 表 3
Heskamp S, Boerman O, Molkenboer Kuenen J, Wauters C, Strobbe L, Mandigers C, et al. Upregulation of IGF-1R expression during neoadjuvant therapy predicts poor outcome in breast cancer patients. PLoS ONE. 2015;10:e0117745 pubmed 出版商
  • 免疫组化; 人类; 1:50
Oon M, Thike A, Tan S, Tan P. Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast. Breast Cancer Res Treat. 2015;150:31-41 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:80
Simons M, Nagtegaal I, Overbeek L, Flucke U, Massuger L, Bulten J. A patient with a noninvasive mucinous ovarian borderline tumor presenting with late pleural metastases. Int J Gynecol Pathol. 2015;34:143-50 pubmed 出版商
  • 免疫组化; 人类; 1:200
Liu J, Yu Y, Sun J, He S, Wang X, Yin J, et al. Clinicopathologic characteristics and prognosis of primary squamous cell carcinoma of the breast. Breast Cancer Res Treat. 2015;149:133-40 pubmed 出版商
  • 免疫组化; 人类
Ahn H, Kim M, Kim M, Cho S, Kim Y, Lee G, et al. Loss of ER? expression in papillary thyroid carcinoma is associated with recurrence in young female. Clin Endocrinol (Oxf). 2015;82:300-6 pubmed 出版商
  • 免疫组化; 人类; 1:400
Argon A, Åžener A, ZekioÄŸlu O, Kapkaç M, Özdemir N. The effect of freezing on the immunoprofile of breast carcinoma cells. Balkan Med J. 2014;31:335-9 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:50
Baccelli I, Stenzinger A, Vogel V, Pfitzner B, Klein C, Wallwiener M, et al. Co-expression of MET and CD47 is a novel prognosticator for survival of luminal breast cancer patients. Oncotarget. 2014;5:8147-60 pubmed
  • 免疫组化; 人类; 1:500
Carvalho F, Bacchi L, Pincerato K, van de Rijn M, Bacchi C. Geographic differences in the distribution of molecular subtypes of breast cancer in Brazil. BMC Womens Health. 2014;14:102 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:100
Mingels M, Masadah R, Geels Y, Otte Holler I, de Kievit I, van der Laak J, et al. High prevalence of atypical hyperplasia in the endometrium of patients with epithelial ovarian cancer. Am J Clin Pathol. 2014;142:213-21 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:100; 图 2
Syed B, Green A, Nolan C, Morgan D, Ellis I, Cheung K. Biological characteristics and clinical outcome of triple negative primary breast cancer in older women - comparison with their younger counterparts. PLoS ONE. 2014;9:e100573 pubmed 出版商
  • 免疫印迹; 人类
Wright P, Jones S, Ardern N, Ward R, Clarke R, Sotgia F, et al. 17?-estradiol regulates giant vesicle formation via estrogen receptor-alpha in human breast cancer cells. Oncotarget. 2014;5:3055-65 pubmed
  • 免疫组化; 人类; 1:400
Chan A, Tong J, Sung M, Lai P, To K. Epstein-Barr virus-associated lymphoepithelioma-like cholangiocarcinoma: a rare variant of intrahepatic cholangiocarcinoma with favourable outcome. Histopathology. 2014;65:674-83 pubmed 出版商
  • 免疫组化; 人类; 1:80
van der Post R, Bult P, Vogelaar I, Ligtenberg M, Hoogerbrugge N, van Krieken J. HNF4A immunohistochemistry facilitates distinction between primary and metastatic breast and gastric carcinoma. Virchows Arch. 2014;464:673-9 pubmed 出版商
  • 免疫组化; 人类; 1:25
Zhang H, Cohen A, Krishnakumar S, Wapnir I, Veeriah S, Deng G, et al. Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition. Breast Cancer Res. 2014;16:R36 pubmed 出版商
  • 免疫组化; 人类; 1:200
Kim E, Kim J, Lee Y, Chong G, Park J, Hong D. Comparison of estrogen receptor-?, progesterone receptor and calponin expression in gonadotrophin-releasing hormone agonist-sensitive and -resistant uterine fibroids. Obstet Gynecol Sci. 2014;57:144-50 pubmed 出版商
  • 免疫组化; 小鼠; 1:1000
Park B, Pan B, Toms D, Huynh E, Byun J, Lee Y, et al. Ovarian-cell-like cells from skin stem cells restored estradiol production and estrus cycling in ovariectomized mice. Stem Cells Dev. 2014;23:1647-58 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:500
Liu Y, Nenutil R, Appleyard M, Murray K, Boylan M, Thompson A, et al. Lack of correlation of stem cell markers in breast cancer stem cells. Br J Cancer. 2014;110:2063-71 pubmed 出版商
  • 免疫组化-石蜡切片; 人类
Neumeister V, Parisi F, England A, Siddiqui S, Anagnostou V, Zarrella E, et al. A tissue quality index: an intrinsic control for measurement of effects of preanalytical variables on FFPE tissue. Lab Invest. 2014;94:467-74 pubmed 出版商
  • 免疫组化; 人类; 1:150
Irshad S, Gillett C, Pinder S, A hern R, Dowsett M, Ellis I, et al. Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer. Breast Cancer Res Treat. 2014;144:331-41 pubmed 出版商
  • 免疫印迹; 人类; 1:5000
Kirkegaard T, Hansen S, Larsen S, Reiter B, Sørensen B, Lykkesfeldt A. T47D breast cancer cells switch from ER/HER to HER/c-Src signaling upon acquiring resistance to the antiestrogen fulvestrant. Cancer Lett. 2014;344:90-100 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:200
Kővári B, Rusz O, Schally A, Kahan Z, Cserni G. Differential immunostaining of various types of breast carcinomas for growth hormone-releasing hormone receptor - Apocrine epithelium and carcinomas emerging as uniformly positive. APMIS. 2014;122:824-31 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:100
Park H, Jang M, Kim E, Kim H, Lee H, Kim Y, et al. High EGFR gene copy number predicts poor outcome in triple-negative breast cancer. Mod Pathol. 2014;27:1212-22 pubmed 出版商
  • 免疫组化; 人类; 1:100
Caffrey E, Ingoldsby H, Wall D, Webber M, Dinneen K, Murillo L, et al. Prognostic significance of deregulated dicer expression in breast cancer. PLoS ONE. 2013;8:e83724 pubmed 出版商
  • 免疫组化; 人类
Boecker W, Stenman G, Loening T, Andersson M, Sinn H, Barth P, et al. Differentiation and histogenesis of syringomatous tumour of the nipple and low-grade adenosquamous carcinoma: evidence for a common origin. Histopathology. 2014;65:9-23 pubmed 出版商
  • 免疫组化; 人类; 1:50
Kommoss S, Gilks C, Penzel R, Herpel E, Mackenzie R, Huntsman D, et al. A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary. Histopathology. 2014;64:380-8 pubmed 出版商
  • 免疫组化; 人类
Hrstka R, Brychtova V, Fabian P, Vojtesek B, Svoboda M. AGR2 predicts tamoxifen resistance in postmenopausal breast cancer patients. Dis Markers. 2013;35:207-12 pubmed 出版商
  • 免疫组化; 人类
Epitropou G, Kavvadias V, Iliou D, Stathopoulos E, Balas C. A real-time spectral mapper as an emerging diagnostic technology in biomedical sciences. Conf Proc IEEE Eng Med Biol Soc. 2013;2013:1422-5 pubmed 出版商
  • 免疫组化; 人类
Madeira M, Mattar A, Logullo A, Soares F, Gebrim L. Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness-a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer. BMC Cancer. 2013;13:425 pubmed 出版商
  • 免疫组化; 人类
Kusafuka K, Onitsuka T, Muramatsu K, Miki T, Murai C, Suda T, et al. Salivary duct carcinoma with rhabdoid features: report of 2 cases with immunohistochemical and ultrastructural analyses. Head Neck. 2014;36:E28-35 pubmed 出版商
  • 免疫组化; 人类; 1:50
Brunelli M, Manfrin E, Bria E, Massari F, Tortora G, Brunello E, et al. HER2/neu gene determination in women screened for breast carcinoma: how screening programs reduce the skyrocketing cost of targeted therapy. Anticancer Res. 2013;33:3705-10 pubmed
  • 免疫组化-石蜡切片; 人类; 1:60
Dewaele B, Przybyl J, Quattrone A, Finalet Ferreiro J, Vanspauwen V, Geerdens E, et al. Identification of a novel, recurrent MBTD1-CXorf67 fusion in low-grade endometrial stromal sarcoma. Int J Cancer. 2014;134:1112-22 pubmed 出版商
  • 免疫组化; 人类; 1:100
Argenta P, Um I, Kay C, Harrison D, Faratian D, Sueblinvong T, et al. Predicting response to the anti-estrogen fulvestrant in recurrent ovarian cancer. Gynecol Oncol. 2013;131:368-73 pubmed 出版商
  • 免疫组化; 人类; 1:50
Brunello E, Bogina G, Bria E, Vergine M, Zamboni G, Pedron S, et al. The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma. J Cancer Res Clin Oncol. 2013;139:1563-8 pubmed 出版商
  • 免疫印迹; 人类; 1:500
Bjerre C, Vinther L, Belling K, Würtz S, Yadav R, Lademann U, et al. TIMP1 overexpression mediates resistance of MCF-7 human breast cancer cells to fulvestrant and down-regulates progesterone receptor expression. Tumour Biol. 2013;34:3839-51 pubmed 出版商
  • 免疫组化; 人类; 1:200
Do S, Kim K, Kim D, Chae S, Park Y, Park C, et al. Associations between the Expression of Mucins (MUC1, MUC2, MUC5AC, and MUC6) and Clinicopathologic Parameters of Human Breast Ductal Carcinomas. J Breast Cancer. 2013;16:152-8 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:200; 图 2
Zhang J, Wang Y, Yin Q, Zhang W, Zhang T, Niu Y. An associated classification of triple negative breast cancer: the risk of relapse and the response to chemotherapy. Int J Clin Exp Pathol. 2013;6:1380-91 pubmed
  • 免疫组化; 人类
Hussein O, Mosbah M, Farouk O, Farag K, El Saed A, Arafa M, et al. Hormone receptors and age distribution in breast cancer patients at a university hospital in northern egypt. Breast Cancer (Auckl). 2013;7:51-7 pubmed 出版商
  • 免疫组化-石蜡切片; 人类
Kourelis K, Tsue T, Girod D, Tawfik O, Sykes K, Shnayder Y. Negative prognostic factors for head and neck cancer in the young. J BUON. 2013;18:459-64 pubmed
  • 免疫组化; 人类; 1:50
Shin S, Lal A, De Vries S, Suzuki J, Roy R, Hwang E, et al. Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situ. Hum Pathol. 2013;44:1998-2009 pubmed 出版商
  • 免疫组化; 人类
Fawzy M, Aly N, Shalaby S, El Sawy W, Abdul Maksoud R. Cyclooxygenase-2 169C>G and 8473T>C gene polymorphisms and prostaglandin E2 level in breast cancer: a case-control study. Gene. 2013;527:601-5 pubmed 出版商
  • 免疫组化; 人类; 1:200
Lai H, Tseng L, Chang T, Kuo Y, Hsieh C, Chen S, et al. The prognostic significance of metaplastic carcinoma of the breast (MCB)--a case controlled comparison study with infiltrating ductal carcinoma. Breast. 2013;22:968-73 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:500; 表 1
Aguiar F, Mendes H, Cirqueira C, Bacchi C, Carvalho F. Basal cytokeratin as a potential marker of low risk of invasion in ductal carcinoma in situ. Clinics (Sao Paulo). 2013;68:638-43 pubmed 出版商
  • 免疫组化; 人类
Hao J, Yang C, Liu F, Yang Y, Li S, Li W, et al. Accessory breast cancer occurring concurrently with bilateral primary invasive breast carcinomas: a report of two cases and literature review. Cancer Biol Med. 2012;9:197-201 pubmed 出版商
  • 免疫组化; 人类; 1:50; 图 1
Palmieri C, Gojis O, Rudraraju B, Stamp Vincent C, Wilson D, Langdon S, et al. Expression of steroid receptor coactivator 3 in ovarian epithelial cancer is a poor prognostic factor and a marker for platinum resistance. Br J Cancer. 2013;108:2039-44 pubmed 出版商
  • 免疫组化; 人类; 1:100
Ingoldsby H, Webber M, Wall D, Scarrott C, Newell J, Callagy G. Prediction of Oncotype DX and TAILORx risk categories using histopathological and immunohistochemical markers by classification and regression tree (CART) analysis. Breast. 2013;22:879-86 pubmed 出版商
  • 免疫组化; 人类; 1:400
Gudlaugsson E, Klos J, Skaland I, Janssen E, Smaaland R, Feng W, et al. Prognostic comparison of the proliferation markers (mitotic activity index, phosphohistone H3, Ki67), steroid receptors, HER2, high molecular weight cytokeratins and classical prognostic factors in T???N?M? breast cancer. Pol J Pathol. 2013;64:1-8 pubmed
  • 免疫印迹; 人类
Thrane S, Lykkesfeldt A, Larsen M, Sorensen B, Yde C. Estrogen receptor ? is the major driving factor for growth in tamoxifen-resistant breast cancer and supported by HER/ERK signaling. Breast Cancer Res Treat. 2013;139:71-80 pubmed 出版商
  • 免疫组化; 小鼠; 1:50
Baccelli I, Schneeweiss A, Riethdorf S, Stenzinger A, Schillert A, Vogel V, et al. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol. 2013;31:539-44 pubmed 出版商
  • 免疫组化; 人类
Brouckaert O, Laenen A, Wildiers H, Floris G, Moerman P, Van Limbergen E, et al. The prognostic role of preoperative and (early) postoperatively change in CA15.3 serum levels in a single hospital cohort of primary operable breast cancers. Breast. 2013;22:254-62 pubmed 出版商
  • 免疫细胞化学; 人类; 1:50
Lee M, Lee C, Tan P. Hormone receptor expression in breast cancer: postanalytical issues. J Clin Pathol. 2013;66:478-84 pubmed 出版商
  • 免疫组化; 人类; 1:100
Kim S, Kim D, Jung W, Koo J. Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer. Endocr Relat Cancer. 2013;20:339-48 pubmed 出版商
  • 免疫印迹; 人类
Harrison H, Simões B, Rogerson L, Howell S, Landberg G, Clarke R. Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling. Breast Cancer Res. 2013;15:R21 pubmed 出版商
  • 免疫组化; 人类; 1:200
Makroo R, Chowdhry M, Kumar M, Srivastava P, Tyagi R, Bhadauria P, et al. Correlation between HER2 gene amplification and protein overexpression through fluorescence in situ hybridization and immunohistochemistry in breast carcinoma patients. Indian J Pathol Microbiol. 2012;55:481-4 pubmed 出版商
  • 免疫组化; 人类; 1:100
Xu J, Wu X, Zhou W, Liu A, Wu J, Deng J, et al. Aurora-A identifies early recurrence and poor prognosis and promises a potential therapeutic target in triple negative breast cancer. PLoS ONE. 2013;8:e56919 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:100; 图 1
Corrêa N, Kuasne H, Faria J, Seixas C, Santos I, Abreu F, et al. Genomic and phenotypic profiles of two Brazilian breast cancer cell lines derived from primary human tumors. Oncol Rep. 2013;29:1299-307 pubmed 出版商
  • 免疫组化; 人类; 1:100
Grabau D, Bendahl P, Rydén L, Stal O, Fernö M. The prevalence of immunohistochemically determined oestrogen receptor positivity in primary breast cancer is dependent on the choice of antibody and method of heat-induced epitope retrieval - prognostic implications?. Acta Oncol. 2013;52:1657-66 pubmed 出版商
  • 免疫细胞化学; 人类
  • 免疫印迹; 人类
Bock C, Rack B, Kuhn C, Hofmann S, Finkenzeller C, Jäger B, et al. Heterogeneity of ER? and ErbB2 Status in Cell Lines and Circulating Tumor Cells of Metastatic Breast Cancer Patients. Transl Oncol. 2012;5:475-85 pubmed
  • 免疫组化; 人类; 1:100
Koo J, Han K, Kim M, Moon H, Kim E, Park B. Can additional immunohistochemistry staining replace the surgical excision for the diagnosis of papillary breast lesions classified as benign on 14-gage core needle biopsy?. Breast Cancer Res Treat. 2013;137:797-806 pubmed 出版商
  • 免疫组化; 人类; 1:100
Choi J, Baek H, Kim S, Kim M, Youk J, Moon H, et al. HR-MAS MR spectroscopy of breast cancer tissue obtained with core needle biopsy: correlation with prognostic factors. PLoS ONE. 2012;7:e51712 pubmed 出版商
  • 免疫组化; 人类; 1:50
Brunello E, Brunelli M, Bogina G, Caliò A, Manfrin E, Nottegar A, et al. FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma. J Exp Clin Cancer Res. 2012;31:103 pubmed 出版商
  • 免疫细胞化学; 人类; 1:100
  • 免疫组化; 人类
Jambal P, Badtke M, Harrell J, Borges V, Post M, Sollender G, et al. Estrogen switches pure mucinous breast cancer to invasive lobular carcinoma with mucinous features. Breast Cancer Res Treat. 2013;137:431-48 pubmed 出版商
  • 免疫组化; 人类; 1:100
Choi J, Kim M, Youk J, Moon H, Suh H, Kim E. US-guided optical tomography: correlation with clinicopathologic variables in breast cancer. Ultrasound Med Biol. 2013;39:233-40 pubmed 出版商
  • 免疫组化; 人类
Hashad D, Sorour A, Ghazal A, Talaat I. Free circulating tumor DNA as a diagnostic marker for breast cancer. J Clin Lab Anal. 2012;26:467-72 pubmed 出版商
  • 免疫组化; 人类
Rau K, Huang C, Chiu T, Chen Y, Lu C, Liu C, et al. Neovascularization evaluated by CD105 correlates well with prognostic factors in breast cancers. Exp Ther Med. 2012;4:231-236 pubmed
  • 免疫沉淀; 人类; 1:500
  • 免疫组化; 人类; 1:750
Escobar J, Klimowicz A, Dean M, Chu P, Nation J, Nelson G, et al. Quantification of ER/PR expression in ovarian low-grade serous carcinoma. Gynecol Oncol. 2013;128:371-6 pubmed 出版商
  • 免疫组化; 人类; 1:200
Yang L, Tseng H, Lin C, Chen L, Chen S, Kuo S, et al. Survival benefit of tamoxifen in estrogen receptor-negative and progesterone receptor-positive low grade breast cancer patients. J Breast Cancer. 2012;15:288-95 pubmed 出版商
  • 免疫组化; 人类
  • 免疫印迹; 人类
Neumeister V, Anagnostou V, Siddiqui S, England A, Zarrella E, Vassilakopoulou M, et al. Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissues. J Natl Cancer Inst. 2012;104:1815-24 pubmed 出版商
  • 免疫组化; 人类
Fitzpatrick Swallow V, Helin H, Cane P, Pinder S. Synchronous ductal carcinoma in situ of the breast and within epithelial inclusions in an ipsilateral sentinel lymph node. Hum Pathol. 2013;44:142-4 pubmed 出版商
  • 免疫组化; 人类; 1:100
Kim M, Kim D, Jung W, Koo J. Histological analysis of benign breast imaging reporting and data system categories 4c and 5 breast lesions in imaging study. Yonsei Med J. 2012;53:1203-10 pubmed 出版商
  • 免疫组化; 人类; 1:100
Park B, Park S, Koo J, Kim S, Park J, Cho J, et al. Homeodomain-interacting protein kinase 1 (HIPK1) expression in breast cancer tissues. Jpn J Clin Oncol. 2012;42:1138-45 pubmed 出版商
  • 免疫组化; 人类
Perez G, Olivares I, Rodriguez M, Ceballos G, Garcia Sanchez J. Arginase activity in patients with breast cancer: an analysis of plasma, tumors, and its relationship with the presence of the estrogen receptor. Onkologie. 2012;35:570-4 pubmed 出版商
  • 免疫组化; 人类
Park H, Park S, Cho J, Park J, Kim S, Park B. Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy. J Surg Oncol. 2013;107:388-92 pubmed 出版商
  • 免疫印迹; 人类; 1:250
Kamel D, Brady B, Tabchy A, Mills G, Hennessy B. Proteomic classification of breast cancer. Curr Drug Targets. 2012;13:1495-509 pubmed
  • 免疫组化; 人类; 1:400
Jakate K, Azimi F, Ali R, Lee C, Clarke B, Rasty G, et al. Endometrial sarcomas: an immunohistochemical and JAZF1 re-arrangement study in low-grade and undifferentiated tumors. Mod Pathol. 2013;26:95-105 pubmed 出版商
  • 免疫组化; 人类
Haltas H, Bayrak R, Yenidunya S, Kosehan D, Sen M, Akin K. Invasive lobular carcinoma with extracellular mucin as a distinct variant of lobular carcinoma: a case report. Diagn Pathol. 2012;7:91 pubmed 出版商
  • 免疫组化; 人类; 1:100
Jang M, Kim E, Choi Y, Lee H, Kim Y, Kim J, et al. FGFR1 is amplified during the progression of in situ to invasive breast carcinoma. Breast Cancer Res. 2012;14:R115 pubmed 出版商
  • 免疫组化; 人类
Grell P, Fabian P, Khoylou M, Radova L, Slaby O, Hrstka R, et al. Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab. Int J Oncol. 2012;41:1204-12 pubmed 出版商
  • 免疫组化; 人类; 1:100
Bonzanini M, Morelli L, Bonandini E, Leonardi E, Pertile R, Dalla Palma P. Cytologic features of triple-negative breast carcinoma. Cancer Cytopathol. 2012;120:401-9 pubmed 出版商
  • 免疫组化; 人类; 1:500
Bartel F, Balschun K, Gradhand E, Strauss H, Dittmer J, Hauptmann S. Inverse expression of cystein-rich 61 (Cyr61/CCN1) and connective tissue growth factor (CTGF/CCN2) in borderline tumors and carcinomas of the ovary. Int J Gynecol Pathol. 2012;31:405-15 pubmed 出版商
  • 免疫组化; 人类
Gill M, Paish E, Ronan J, Green A, Ellis I, Lee A. Comparison of the PharmDx immunohistochemical system with standard methods for assessing estrogen and progesterone receptors in invasive carcinoma of the breast. Appl Immunohistochem Mol Morphol. 2013;21:90-3 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 图 2d
  • 免疫组化; 人类; 1:1000
  • 免疫印迹; 人类; 1:500; 图 1b
Welsh A, Harigopal M, Wimberly H, Prasad M, Rimm D. Quantitative analysis of estrogen receptor expression shows SP1 antibody is more sensitive than 1D5. Appl Immunohistochem Mol Morphol. 2013;21:139-47 pubmed 出版商
  • 免疫组化; 小鼠; 1:300
Mustafi R, Dougherty U, Shah H, Dehghan H, Gliksberg A, Wu J, et al. Both stromal cell and colonocyte epidermal growth factor receptors control HCT116 colon cancer cell growth in tumor xenografts. Carcinogenesis. 2012;33:1930-9 pubmed 出版商
  • 免疫组化; 人类; 1:400
Jonsdottir K, Zhang H, Jhagroe D, Skaland I, Slewa A, Björkblom B, et al. The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer. Breast Cancer Res Treat. 2012;135:381-90 pubmed 出版商
  • 免疫组化; 人类
Kasai M, Ichimura T, Kawamura N, Sumikura T, Matsuda M, Asano C, et al. Prediction of the shrinking rate of uterine leiomyoma nodules using needle biopsy specimens. Fertil Steril. 2012;98:440-3 pubmed 出版商
  • 免疫组化; 人类
Liu J, Su T, Shen K, Lin S, Wang H, Hsu J, et al. Vaginal superficial myofibroblastoma: a rare mesenchymal tumor of the lower female genital tract and a study of its association with viral infection. Med Mol Morphol. 2012;45:110-4 pubmed 出版商
  • 免疫组化; 人类; 1:1000
Carvalho F, Carvalho J, Pereira R, Ceccato B, Lacordia R, Baracat E. Leiomyomatosis peritonealis disseminata associated with endometriosis and multiple uterus-like mass: report of two cases. Clin Med Insights Case Rep. 2012;5:63-8 pubmed 出版商
  • 免疫组化; 人类
Kaplan J, Schnitt S, Collins L, Wang Y, Garber J, Montgomery K, et al. Pathologic features and immunophenotype of estrogen receptor-positive breast cancers in BRCA1 mutation carriers. Am J Surg Pathol. 2012;36:1483-8 pubmed 出版商
  • 免疫组化; 人类; 1:1000
  • 免疫印迹; 人类; 1:1000
Bordeaux J, Cheng H, Welsh A, Haffty B, Lannin D, Wu X, et al. Quantitative in situ measurement of estrogen receptor mRNA predicts response to tamoxifen. PLoS ONE. 2012;7:e36559 pubmed 出版商
  • 免疫组化; 人类; 1:200
Chio I, Sasaki M, Ghazarian D, Moreno J, Done S, Ueda T, et al. TRADD contributes to tumour suppression by regulating ULF-dependent p19Arf ubiquitylation. Nat Cell Biol. 2012;14:625-33 pubmed 出版商
  • 免疫组化; 人类
Brouckaert O, Laenen A, Vanderhaegen J, Wildiers H, Leunen K, Amant F, et al. Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancers. Ann Oncol. 2012;23:2578-84 pubmed
  • 免疫组化; 人类; 1:60
Lee C, Mariño Enríquez A, Ou W, Zhu M, Ali R, Chiang S, et al. The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor. Am J Surg Pathol. 2012;36:641-53 pubmed 出版商
  • 免疫组化; 人类
Svoboda M, Sana J, Redova M, Navratil J, Palacova M, Fabian P, et al. MiR-34b is associated with clinical outcome in triple-negative breast cancer patients. Diagn Pathol. 2012;7:31 pubmed 出版商
  • 免疫组化; 人类; 1:25
Rossing H, Talman M, Laenkholm A, Wielenga V. Implementation of TMA and digitalization in routine diagnostics of breast pathology. APMIS. 2012;120:341-7 pubmed 出版商
  • 免疫组化; 人类
Avraham A, Uhlmann R, Shperber A, Birnbaum M, Sandbank J, Sella A, et al. Serum DNA methylation for monitoring response to neoadjuvant chemotherapy in breast cancer patients. Int J Cancer. 2012;131:E1166-72 pubmed 出版商
  • 免疫印迹; 小鼠
Giulianelli S, Vaque J, Soldati R, Wargon V, Vanzulli S, Martins R, et al. Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters. Cancer Res. 2012;72:2416-27 pubmed 出版商
  • 免疫组化; 人类
Zheng S, Bai J, Li J, Fan J, Pang Y, Song Q, et al. The pathologic characteristics of breast cancer in China and its shift during 1999-2008: a national-wide multicenter cross-sectional image over 10 years. Int J Cancer. 2012;131:2622-31 pubmed 出版商
  • 免疫组化; 人类; 1:1000
Cawthorn T, Moreno J, Dharsee M, Tran Thanh D, Ackloo S, Zhu P, et al. Proteomic analyses reveal high expression of decorin and endoplasmin (HSP90B1) are associated with breast cancer metastasis and decreased survival. PLoS ONE. 2012;7:e30992 pubmed 出版商
  • 免疫组化; 人类
Yigit S, Pehlivan F, Evcim G, Etit D. Clinicopathologic features of the mixed epithelial and mesenchymal type metaplastic breast carcinoma with myoepithelial differentiation in a subset of six cases. Pathol Res Pract. 2012;208:147-50 pubmed 出版商
  • 免疫组化; 人类; 1:200
Sanli Y, Kuyumcu S, Ozkan Z, Işık G, Karanlik H, Guzelbey B, et al. Increased FDG uptake in breast cancer is associated with prognostic factors. Ann Nucl Med. 2012;26:345-50 pubmed 出版商
  • 免疫组化; 人类; 1:200
Lin C, Chen D, Chang K, Chang T, Wang H. A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin and trastuzumab for T2 breast cancers. Cancer Chemother Pharmacol. 2012;69:1363-8 pubmed 出版商
  • 免疫细胞化学; 人类; 1:50
Powell E, Shanle E, Brinkman A, Li J, Keles S, Wisinski K, et al. Identification of estrogen receptor dimer selective ligands reveals growth-inhibitory effects on cells that co-express ER? and ER?. PLoS ONE. 2012;7:e30993 pubmed 出版商
  • 免疫组化; 人类; 1:200
Pegolo E, Machin P, Riosa F, Bassini A, Deroma L, Di Loreto C. Hormone receptor and human epidermal growth factor receptor 2 status evaluation on ThinPrep specimens from breast carcinoma: correlation with histologic sections determination. Cancer Cytopathol. 2012;120:196-205 pubmed 出版商
  • 免疫组化; 人类; 1:200
Lin C, Chien S, Kuo S, Chen L, Chen S, Lai H, et al. A 10-year follow-up of triple-negative breast cancer patients in Taiwan. Jpn J Clin Oncol. 2012;42:161-7 pubmed 出版商
  • 免疫组化; 人类; 1:100
Park B, Park S, Park H, Koo J, Yang W, Lee J, et al. Cyclooxygenase-2 expression in proliferative Ki-67-positive breast cancers is associated with poor outcomes. Breast Cancer Res Treat. 2012;133:741-51 pubmed 出版商
  • 免疫组化; 人类
Maae E, Olsen D, Steffensen K, Jakobsen E, Brandslund I, Sørensen F, et al. Prognostic impact of placenta growth factor and vascular endothelial growth factor A in patients with breast cancer. Breast Cancer Res Treat. 2012;133:257-65 pubmed 出版商
  • 免疫组化; 人类
MacFarlane R, Seal M, Speers C, Woods R, Masoudi H, Aparicio S, et al. Molecular alterations between the primary breast cancer and the subsequent locoregional/metastatic tumor. Oncologist. 2012;17:172-8 pubmed 出版商
  • 免疫组化; 人类
Chan S, Vermi W, Luo J, Lucini L, Rickert C, Fowler A, et al. STAT1-deficient mice spontaneously develop estrogen receptor ?-positive luminal mammary carcinomas. Breast Cancer Res. 2012;14:R16 pubmed
  • 免疫组化; 人类; 1:100
Roelofsen T, van Kempen L, van der Laak J, van Ham M, Bulten J, Massuger L. Concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: can EIC be seen as the precursor lesion?. Int J Gynecol Cancer. 2012;22:457-64 pubmed 出版商
  • 免疫组化; 人类; 1:50
Giordano G, Pizzi S, Berretta R, D Adda T. A new case of primary signet-ring cell carcinoma of the cervix with prominent endometrial and myometrial involvement: Immunohistochemical and molecular studies and review of the literature. World J Surg Oncol. 2012;10:7 pubmed 出版商
  • 免疫组化; 人类; 1:100
Park S, Park H, Koo J, Yang W, Kim S, Park B. Higher expression of androgen receptor is a significant predictor for better endocrine-responsiveness in estrogen receptor-positive breast cancers. Breast Cancer Res Treat. 2012;133:311-20 pubmed 出版商
  • 免疫组化; 人类; 1:100
Dong Y, Yang X, Wong O, Zhang X, Liang Y, Zhang Y, et al. PIK3CA mutations in endometrial carcinomas in Chinese women: phosphatidylinositol 3'-kinase pathway alterations might be associated with favorable prognosis. Hum Pathol. 2012;43:1197-205 pubmed 出版商
  • 免疫印迹; 人类
Park Y, Kim K, Kim S, Hennessy B, Kim S, Park E, et al. Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer. EMBO Mol Med. 2012;4:52-67 pubmed 出版商
  • 免疫组化; 人类
Karlsson C, Karlsson M. Effects of long-term storage on the detection of proteins, DNA, and mRNA in tissue microarray slides. J Histochem Cytochem. 2011;59:1113-21 pubmed 出版商
  • 免疫组化; 人类; 1:200
Chen S, Lai H, Tseng H, Chen L, Kuo S, Chen D. Correlation of histologic grade with other clinicopathological parameters, intrinsic subtype, and patients' clinical outcome in Taiwanese women. Jpn J Clin Oncol. 2011;41:1327-35 pubmed 出版商
  • 免疫组化; 人类; 1:100
El Gendi S, Mostafa M, El Gendi A. Stromal caveolin-1 expression in breast carcinoma. Correlation with early tumor recurrence and clinical outcome. Pathol Oncol Res. 2012;18:459-69 pubmed 出版商
  • 免疫细胞化学; 人类; 1:1000
  • 免疫印迹; 人类; 1:500
Welsh A, Lannin D, Young G, Sherman M, Figueroa J, Henry N, et al. Cytoplasmic estrogen receptor in breast cancer. Clin Cancer Res. 2012;18:118-26 pubmed 出版商
  • 免疫组化; 人类
Walsh S, Flanagan L, Quinn C, Evoy D, McDermott E, Pierce A, et al. mTOR in breast cancer: differential expression in triple-negative and non-triple-negative tumors. Breast. 2012;21:178-82 pubmed 出版商
  • 免疫组化; 人类; 1:50
Ulasov I, Kaverina N, Pytel P, Thaci B, Liu F, Hurst D, et al. Clinical significance of KISS1 protein expression for brain invasion and metastasis. Cancer. 2012;118:2096-105 pubmed 出版商
  • 免疫组化; 人类
Keskin S, Muslumanoglu M, Saip P, Karanlik H, Guveli M, Pehlivan E, et al. Clinical and pathological features of breast cancer associated with the pathological complete response to anthracycline-based neoadjuvant chemotherapy. Oncology. 2011;81:30-8 pubmed 出版商
  • 免疫组化; 人类
Park S, Koo J, Kim M, Park H, Lee J, Lee J, et al. Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry. Breast. 2012;21:50-7 pubmed 出版商
  • 免疫组化; 人类
Park H, Lee J, Lee J, Park S, Kim S, Park B. The feasibility of endoscopy-assisted breast conservation surgery for patients with early breast cancer. J Breast Cancer. 2011;14:52-7 pubmed 出版商
  • 免疫组化; 人类; 1:50
Loibl S, Müller B, von Minckwitz G, Schwabe M, Roller M, Darb Esfahani S, et al. Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy. Breast Cancer Res Treat. 2011;130:477-87 pubmed 出版商
  • 免疫组化; 人类; 1:100
Park S, Park H, Koo J, Yang W, Kim S, Park B. Breast cancers presenting luminal B subtype features show higher discordant human epidermal growth factor receptor 2 results between immunohistochemistry and fluorescence in situ hybridization. Cancer. 2012;118:914-23 pubmed 出版商
  • 免疫组化; 小鼠
Naidu R, Har Y, Taib N. Analysis of peptidyl-propyl-cis/trans isomerase 1 (PIN1) gene -842(G > C) and -667(T > C) polymorphic variants in relation to breast cancer risk and clinico-pathological parameters. Scand J Clin Lab Invest. 2011;71:500-6 pubmed 出版商
  • 免疫组化; 人类
Nikolényi A, Sukosd F, Kaizer L, Csörgo E, Voros A, Uhercsak G, et al. Tumor topoisomerase II alpha status and response to anthracycline-based neoadjuvant chemotherapy in breast cancer. Oncology. 2011;80:269-77 pubmed 出版商
  • 免疫组化; 人类; 1:100
Choi Y, Kim E, Seol H, Lee H, Jang M, Kim S, et al. The hormone receptor, human epidermal growth factor receptor 2, and molecular subtype status of individual tumor foci in multifocal/multicentric invasive ductal carcinoma of breast. Hum Pathol. 2012;43:48-55 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:100; 图 1
Cheah P, Looi L, Lee G, Teoh K, Mun K, Nazarina A. Unusual finding of endocervical-like mucinous epithelium in continuity with urothelium in endocervicosis of the urinary bladder. Diagn Pathol. 2011;6:56 pubmed 出版商
  • 免疫印迹; 人类; 1:250
Hennessy B, Lu Y, Gonzalez Angulo A, Carey M, Myhre S, Ju Z, et al. A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers. Clin Proteomics. 2010;6:129-51 pubmed 出版商
  • 免疫组化; 人类; 1:400
Carvalho S, Stiepcich M, Fregnani J, Nonogaki S, Rocha R, Soares F. Evaluation of prognostic factors in stage IIA breast tumors and their correlation with mortality risk. Clinics (Sao Paulo). 2011;66:607-12 pubmed
  • 免疫沉淀; 人类; 5 ug
  • 免疫组化; 人类; 1:100
  • 免疫印迹; 人类
Anbalagan M, Carrier L, Glodowski S, Hangauer D, Shan B, Rowan B. KX-01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor α positive breast cancer. Breast Cancer Res Treat. 2012;132:391-409 pubmed 出版商
  • 免疫细胞化学; 人乳头状瘤病毒; 1:100
Wang Y, Li W, Liu Q, Guan X, Hu J. Dendritic cells treated with HPV16mE7 in a three-dimensional model promote the secretion of IL-12p70 and IFN-?. Exp Mol Pathol. 2011;91:325-30 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:50
Teng Y, Tan W, Thike A, Cheok P, Tse G, Wong N, et al. Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy. Breast Cancer Res. 2011;13:R35 pubmed 出版商
  • 免疫组化; 人类; 1:100
Martins D, Sousa B, Lopes N, Gomes M, Veronese L, Albergaria A, et al. Molecular phenotypes of matched in situ and invasive components of breast carcinomas. Hum Pathol. 2011;42:1438-46 pubmed 出版商
  • 免疫组化; 人类
Kim S, Sohn J, Koo J, Park S, Park H, Park B. Molecular subtypes and tumor response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. Oncology. 2010;79:324-30 pubmed 出版商
  • 免疫组化; 人类; 1:250
Allison K, Kandalaft P, Sitlani C, Dintzis S, Gown A. Routine pathologic parameters can predict Oncotype DX recurrence scores in subsets of ER positive patients: who does not always need testing?. Breast Cancer Res Treat. 2012;131:413-24 pubmed 出版商
  • 免疫组化; 人类; 1:100
Chuah B, Putti T, Salto Tellez M, Charlton A, Iau P, Buhari S, et al. Serial changes in the expression of breast cancer-related proteins in response to neoadjuvant chemotherapy. Ann Oncol. 2011;22:1748-54 pubmed 出版商
  • 免疫组化; 人类
Yip C, Pathy N, Uiterwaal C, Taib N, Tan G, Mun K, et al. Factors affecting estrogen receptor status in a multiracial Asian country: an analysis of 3557 cases. Breast. 2011;20 Suppl 2:S60-4 pubmed 出版商
  • 免疫组化; 人类; 1:50
Müller B, Kronenwett R, Hennig G, Euting H, Weber K, Bohmann K, et al. Quantitative determination of estrogen receptor, progesterone receptor, and HER2 mRNA in formalin-fixed paraffin-embedded tissue--a new option for predictive biomarker assessment in breast cancer. Diagn Mol Pathol. 2011;20:1-10 pubmed 出版商
  • 免疫组化; 人类; 1:400
Gudlaugsson E, Skaland I, Undersrud E, Janssen E, Søiland H, Baak J. D2-40/p63 defined lymph vessel invasion has additional prognostic value in highly proliferating operable node negative breast cancer patients. Mod Pathol. 2011;24:502-11 pubmed 出版商
  • 免疫组化; 人类
Park S, Koo J, Kim M, Park H, Lee J, Kim S, et al. Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers. Ann Oncol. 2011;22:1755-62 pubmed 出版商
  • 免疫组化; 人类; 1:100
Petersson F, Tan P, Hwang J. Sclerosing polycystic adenosis of the parotid gland: report of a bifocal, paucicystic variant with ductal carcinoma in situ and pronounced stromal distortion mimicking invasive carcinoma. Head Neck Pathol. 2011;5:188-92 pubmed 出版商
  • 免疫组化; 人类; 1:250
Baglietto L, Krishnan K, Severi G, Hodge A, Brinkman M, English D, et al. Dietary patterns and risk of breast cancer. Br J Cancer. 2011;104:524-31 pubmed 出版商
  • 免疫组化; 人类; 1:300
Ege C, Akbulut M, Zekioglu O, Ozdemir N. Investigation of galectin-3 and heparanase in endometrioid and serous carcinomas of the endometrium and correlation with known predictors of survival. Arch Gynecol Obstet. 2011;284:1231-9 pubmed 出版商
  • 免疫组化; 人类; 1:100
Park S, Kwon H, Lee H, Ryu H, Kim S, Kim J, et al. Promoter CpG island hypermethylation during breast cancer progression. Virchows Arch. 2011;458:73-84 pubmed 出版商
  • 免疫印迹; 人类; 1:400
Brown C, Ahmad Z, Ryan A, Doherty J. Estrogen receptor expression in sporadic vestibular schwannomas. Otol Neurotol. 2011;32:158-62 pubmed 出版商
  • 免疫组化; 人类; 1:200
Lai H, Kuo S, Chen L, Chi C, Chen S, Chang T, et al. Prognostic significance of triple negative breast cancer at tumor size 1 cm and smaller. Eur J Surg Oncol. 2011;37:18-24 pubmed 出版商
  • 免疫组化; 人类
Wynendaele J, Böhnke A, Leucci E, Nielsen S, Lambertz I, Hammer S, et al. An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity. Cancer Res. 2010;70:9641-9 pubmed 出版商
  • 免疫组化; 人类
Kosemehmetoglu K, Guler G. Papillary apocrine metaplasia and columnar cell lesion with atypia: is there a shared common pathway?. Ann Diagn Pathol. 2010;14:425-31 pubmed 出版商
  • 免疫组化; 人类; 1:1
Abdelzaher E, El Gendi S, Yehya A, Gowil A. Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression. Br J Neurosurg. 2011;25:707-13 pubmed 出版商
  • 免疫组化; 小鼠; 1:20
Spillman M, Manning N, Dye W, Sartorius C, Post M, Harrell J, et al. Tissue-specific pathways for estrogen regulation of ovarian cancer growth and metastasis. Cancer Res. 2010;70:8927-36 pubmed 出版商
  • 免疫印迹; 人类; 1:100
Willing C, Peich M, Danescu A, Kehlen A, Fowler P, Hombach Klonisch S. Estrogen-independent actions of environmentally relevant AhR-agonists in human endometrial epithelial cells. Mol Hum Reprod. 2011;17:115-26 pubmed 出版商
  • 免疫组化; 人类
Kusafuka K, Itoh H, Sugiyama C, Nakajima T. Low-grade salivary duct carcinoma of the parotid gland: report of a case with immunohistochemical analysis. Med Mol Morphol. 2010;43:178-84 pubmed 出版商
  • 免疫组化; 人类
Rhodes A, Sarson J, Assam E, Dean S, Cribb E, Parker A. The reliability of rabbit monoclonal antibodies in the immunohistochemical assessment of estrogen receptors, progesterone receptors, and HER2 in human breast carcinomas. Am J Clin Pathol. 2010;134:621-32 pubmed 出版商
  • 免疫组化; 人类; 1:50
Lwin Z, Guo C, Salim A, Yip G, Chew F, Nan J, et al. Clinicopathological significance of calreticulin in breast invasive ductal carcinoma. Mod Pathol. 2010;23:1559-66 pubmed 出版商
  • 免疫印迹; 人类; 1:400
Janssen E, Slewa A, Gudlaugsson E, Jonsdottir K, Skaland I, Søiland H, et al. Biologic profiling of lymph node negative breast cancers by means of microRNA expression. Mod Pathol. 2010;23:1567-76 pubmed 出版商
  • 免疫组化; 人类; 1:150
Giordano G, Lombardi M, Brigati F, Mancini C, Silini E. Clinicopathologic features of 2 new cases of uterine tumors resembling ovarian sex cord tumors. Int J Gynecol Pathol. 2010;29:459-67 pubmed 出版商
  • 免疫组化; 人类; 1:200
Chen C, Xia H, Gong Y, Peng J, Peng C, Hu M, et al. The quantitative detection of total HER2 load by quantum dots and the identification of a new subtype of breast cancer with different 5-year prognosis. Biomaterials. 2010;31:8818-25 pubmed 出版商
  • 免疫组化; 小鼠; 1:500
Olsen C, Moreira J, Lukanidin E, Ambartsumian N. Human mammary fibroblasts stimulate invasion of breast cancer cells in a three-dimensional culture and increase stroma development in mouse xenografts. BMC Cancer. 2010;10:444 pubmed 出版商
  • 免疫组化; 人类; 1:75
Baydar D, Kulac I, Gurel B, De Marzo A. A case of prostatic adenocarcinoma with aberrant p63 expression: presentation with detailed immunohistochemical study and FISH analysis. Int J Surg Pathol. 2011;19:131-6 pubmed 出版商
  • 免疫组化; 人类; 1:50
Huober J, von Minckwitz G, Denkert C, Tesch H, Weiss E, Zahm D, et al. Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study. Breast Cancer Res Treat. 2010;124:133-40 pubmed 出版商
  • 免疫组化; 人类; 1:250
Baehner F, Achacoso N, Maddala T, Shak S, Quesenberry C, Goldstein L, et al. Human epidermal growth factor receptor 2 assessment in a case-control study: comparison of fluorescence in situ hybridization and quantitative reverse transcription polymerase chain reaction performed by central laboratories. J Clin Oncol. 2010;28:4300-6 pubmed 出版商
  • 免疫组化; 人类
Vranic S, Frkovic Grazio S, Lamovec J, Serdarevic F, Gurjeva O, Palazzo J, et al. Adenoid cystic carcinomas of the breast have low Topo II? expression but frequently overexpress EGFR protein without EGFR gene amplification. Hum Pathol. 2010;41:1617-23 pubmed 出版商
  • 免疫组化; 人类
Carvalho L, Pereira E, Frappart L, Boniol M, Bernardo W, Tarricone V, et al. Molecular characterization of breast cancer in young Brazilian women. Rev Assoc Med Bras (1992). 2010;56:278-87 pubmed
  • 免疫细胞化学; 人类
  • 免疫印迹; 人类
Kabos P, Haughian J, Wang X, Dye W, Finlayson C, Elias A, et al. Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers. Breast Cancer Res Treat. 2011;128:45-55 pubmed 出版商
  • 免疫细胞化学; 人类; 1:100
  • 免疫组化; 人类; 1:100
Bohn O, Fuertes Camilo M, Navarro L, Saldivar J, Sanchez Sosa S. p16INK4a expression in basal-like breast carcinoma. Int J Clin Exp Pathol. 2010;3:600-7 pubmed
  • 免疫组化; 人类; 1:200
Tran Thanh D, Arneson N, Pintilie M, Deliallisi A, Warren K, Bane A, et al. Amplification of the prolactin receptor gene in mammary lobular neoplasia. Breast Cancer Res Treat. 2011;128:31-40 pubmed 出版商
  • 免疫印迹; 人类; 图 1
Rasmussen L, Frederiksen K, Din N, Galsgaard E, Christensen L, Berchtold M, et al. Prolactin and oestrogen synergistically regulate gene expression and proliferation of breast cancer cells. Endocr Relat Cancer. 2010;17:809-22 pubmed 出版商
  • 免疫组化; 人类; 1:200
Alkushi A, Köbel M, Kalloger S, Gilks C. High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes. Int J Gynecol Pathol. 2010;29:343-50 pubmed 出版商
  • 免疫印迹; 人类
Kvardova V, Hrstka R, Walerych D, Muller P, Matoulkova E, Hruskova V, et al. The new platinum(IV) derivative LA-12 shows stronger inhibitory effect on Hsp90 function compared to cisplatin. Mol Cancer. 2010;9:147 pubmed 出版商
  • 免疫印迹; 人类
Hrstka R, Nenutil R, Fourtouna A, Maslon M, Naughton C, Langdon S, et al. The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers. Oncogene. 2010;29:4838-47 pubmed 出版商
  • 免疫细胞化学; 人类
Miller T, Hennessy B, Gonzalez Angulo A, Fox E, Mills G, Chen H, et al. Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer. J Clin Invest. 2010;120:2406-13 pubmed 出版商
  • 免疫组化; 人类; 1:100
Giordano G, Bersiga A, Marchetti G, Melpignano M. Primary adenocarcinoma of the rectovaginal septum arising in pregnancy in the absence of endometriosis. Eur J Gynaecol Oncol. 2010;31:211-3 pubmed
  • 免疫组化; 人类; 1:300
Zekioglu O, Ozdemir N, Terek C, Ozsaran A, Dikmen Y. Clinicopathological and immunohistochemical analysis of sclerosing stromal tumours of the ovary. Arch Gynecol Obstet. 2010;282:671-6 pubmed 出版商
  • 免疫组化; 人类; 1:100
Munjal K, Ambaye A, Evans M, Mitchell J, Nandedkar S, Cooper K. Immunohistochemical analysis of ER, PR, Her2 and CK5/6 in infiltrative breast carcinomas in Indian patients. Asian Pac J Cancer Prev. 2009;10:773-8 pubmed
  • 免疫组化; 人类; 1:100
Wang H, Guan B, Shi Q, Ma H, Zhou H, Wang X, et al. May metaplastic breast carcinomas be actually basal-like carcinoma? Further evidence study with its ultrastructure and survival analysis. Med Oncol. 2011;28:42-50 pubmed 出版商
  • 免疫组化; 人类; 1:100
Nykanen M, Kuopio T. Protein and gene expression of estrogen receptor alpha and nuclear morphology of two breast cancer cell lines after different fixation methods. Exp Mol Pathol. 2010;88:265-71 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 表 1
Leong A, Haffajee Z. Citraconic anhydride: a new antigen retrieval solution. Pathology. 2010;42:77-81 pubmed 出版商
  • 免疫组化; 人类; 1:400
Pathmanathan N, Salisbury E, Provan P, Bilous A, Byth K, Milliken J, et al. A class discovery and class prediction approach to histopathological classification of mammographic screen detected columnar cell lesions of the breast. Pathology. 2010;42:28-36 pubmed 出版商
  • 免疫组化; 人类
Faggad A, Budczies J, Tchernitsa O, Darb Esfahani S, Sehouli J, Müller B, et al. Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression. J Pathol. 2010;220:382-91 pubmed 出版商
  • 免疫组化; 人类
Habel L, Achacoso N, Haque R, Nekhlyudov L, Fletcher S, Schnitt S, et al. Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting. Breast Cancer Res. 2009;11:R85 pubmed 出版商
  • 免疫组化; 人类; 1:150
Lopes N, Sousa B, Vieira D, Milanezi F, Schmitt F. Vessel density assessed by endoglin expression in breast carcinomas with different expression profiles. Histopathology. 2009;55:594-9 pubmed 出版商
  • 免疫组化; 人类
Park S, Koo J, Park H, Kim J, Choi S, Lee J, et al. Expression of androgen receptors in primary breast cancer. Ann Oncol. 2010;21:488-92 pubmed 出版商
  • 免疫组化; 人类; 1:50
Gomez Fernandez C, Mejias A, Walker G, Nadji M. Immunohistochemical expression of estrogen receptor in adenocarcinomas of the lung: the antibody factor. Appl Immunohistochem Mol Morphol. 2010;18:137-41 pubmed 出版商
  • 免疫组化; 人类; 1:50
Thike A, Cheok P, Jara Lazaro A, Tan B, Tan P, Tan P. Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer. Mod Pathol. 2010;23:123-33 pubmed 出版商
  • 免疫组化; 人类
Chen H, Huang H, Li C, Ko S, Changchien C, Chen W, et al. Synchronous presentation of uterine leiomyosarcoma and retroperitoneal liposarcoma: analysis by comparative genomic hybridization and review of the literature. Int J Gynecol Pathol. 2009;28:535-40 pubmed 出版商
  • 免疫组化; 人类
Rejnmark L, Tietze A, Vestergaard P, Buhl L, Lehbrink M, Heickendorff L, et al. Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev. 2009;18:2655-60 pubmed 出版商
  • 免疫组化; 人类; 1:300
Colette S, Defrere S, Lousse J, Van Langendonckt A, Loumaye E, Donnez J. Evaluation of estrogen treatment in an immunodeficient mouse endometriosis model. Gynecol Obstet Invest. 2009;68:262-8 pubmed 出版商
  • 免疫组化; 人类; 1:50
Darb Esfahani S, Loibl S, Müller B, Roller M, Denkert C, Komor M, et al. Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy. Breast Cancer Res. 2009;11:R69 pubmed 出版商
  • 免疫印迹; 人类; 1:100
Chang C, Chiou P, Chen W, Li Y, Yiu J, Cheng Y, et al. Assessment of the tumorigenesis and drug susceptibility of three new canine mammary tumor cell lines. Res Vet Sci. 2010;88:285-93 pubmed 出版商
  • 免疫组化; 人类
Wang L, Jiang Z, Sui M, Shen J, Xu C, Fan W. The potential biomarkers in predicting pathologic response of breast cancer to three different chemotherapy regimens: a case control study. BMC Cancer. 2009;9:226 pubmed 出版商
  • 免疫组化; 人类; 1:200
Locati L, Perrone F, Losa M, Mela M, Casieri P, Orsenigo M, et al. Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs). Oral Oncol. 2009;45:986-90 pubmed 出版商
  • 免疫组化; 人类; 1:400
Gudlaugsson E, Skaland I, Janssen E, van Diest P, Voorhorst F, Kjellevold K, et al. Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer. Breast Cancer Res Treat. 2010;121:35-40 pubmed 出版商
  • 免疫组化; 人类
Christgen M, Christgen H, Heil C, Krech T, Langer F, Kreipe H, et al. Expression of KAI1/CD82 in distant metastases from estrogen receptor-negative breast cancer. Cancer Sci. 2009;100:1767-71 pubmed 出版商
  • 免疫印迹; 人类; 1:200
Lin C, Chien S, Chen L, Kuo S, Chang T, Chen D. Triple negative breast carcinoma is a prognostic factor in Taiwanese women. BMC Cancer. 2009;9:192 pubmed 出版商
  • 免疫组化; 人类
Karlsson C, Bodin L, Piehl Aulin K, Karlsson M. Tissue microarray validation: a methodologic study with special reference to lung cancer. Cancer Epidemiol Biomarkers Prev. 2009;18:2014-21 pubmed 出版商
  • 免疫组化; 人类
Gul A, Ugur M, Iskender C, Zulfikaroglu E, Ozaksit G. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and its relationship to clinical parameters. Arch Gynecol Obstet. 2010;281:479-83 pubmed 出版商
  • 免疫组化; 人类; 1:300
Rocha R, Nunes C, Sanches F, Rocha G, Oliveira F, Reis Filho J, et al. Rabbit antibodies for hormone receptors and HER2 evaluation in breast cancer. Rev Assoc Med Bras (1992). 2009;55:163-8 pubmed
  • 免疫组化; 人类; 1:150
Dufloth R, Alves J, Martins D, Vieira D, Chikota H, Zeferino L, et al. Cytological criteria to predict basal phenotype of breast carcinomas. Diagn Cytopathol. 2009;37:809-14 pubmed 出版商
  • 免疫组化; 人类; 1:25
Blance R, Sims A, Anderson E, Howell A, Clarke R. Normal breast tissue implanted into athymic nude mice identifies biomarkers of the effects of human pregnancy levels of estrogen. Cancer Prev Res (Phila). 2009;2:257-64 pubmed 出版商
  • 免疫组化; 人类; 1:200
Tezel G, Uner A, Yildiz I, Guler G, Takahashi M. RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression. Pathol Res Pract. 2009;205:403-8 pubmed 出版商
  • 免疫组化; 人类; 1:200
Khan S, Lankes H, Patil D, Bryk M, Hou N, Ivancic D, et al. Ductal lavage is an inefficient method of biomarker measurement in high-risk women. Cancer Prev Res (Phila). 2009;2:265-73 pubmed 出版商
  • 免疫组化; 人类; 1:100
Hanley K, Siddiqui M, Lawson D, Cohen C, Nassar A. Evaluation of new monoclonal antibodies in detection of estrogen receptor, progesterone receptor, and Her2 protein expression in breast carcinoma cell block sections using conventional microscopy and quantitative image analysis. Diagn Cytopathol. 2009;37:251-7 pubmed 出版商
  • 免疫组化; 人类; 1:250
Liu S, Chia S, Mehl E, Leung S, Rajput A, Cheang M, et al. Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients. Breast Cancer Res Treat. 2010;119:53-61 pubmed 出版商
  • 免疫组化; 人类
Thorat M, Mehrotra S, Morimiya A, Badve S. COX-2 expression does not correlate with microvessel density in breast cancer. Pathobiology. 2009;76:39-44 pubmed 出版商
  • 免疫组化; 人类; 1:50
Ma X, Dahiya S, Richardson E, Erlander M, Sgroi D. Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res. 2009;11:R7 pubmed 出版商
  • 免疫组化; 人类
Kaya A, Ulus A, Bayri Y, Topal A, Gun S, Kandemir B, et al. There are no estrogen and progesterone receptors in cerebral cavernomas: a preliminary immunohistochemical study. Surg Neurol. 2009;72:263-5; discussion 265 pubmed 出版商
  • 免疫组化; 人类; 1:100
Froio E, D Adda T, Fellegara G, Martella E, Caruana P, Pruneri G, et al. Uterine carcinosarcoma metastatic to the lung as large-cell neuroendocrine carcinoma with synchronous sarcoid granulomatosis. Lung Cancer. 2009;64:371-7 pubmed 出版商
  • 免疫组化; 人类; 1:400
Søiland H, Skaland I, Varhaug J, Kørner H, Janssen E, Gudlaugsson E, et al. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients. Acta Oncol. 2009;48:514-21 pubmed 出版商
  • 免疫组化; 人类
Thorat M, Turbin D, Morimiya A, Leung S, Zhang Q, Jeng M, et al. Amplified in breast cancer 1 expression in breast cancer. Histopathology. 2008;53:634-41 pubmed
  • 免疫组化; 人类; 1:200
Zhou C, Zhang Q, Zhang T, Sun S, Li H, Wang Y, et al. Expression of ER, Ki-67 and cylinD1 in the pre-cancerous breast of Chinese patients. Pathol Oncol Res. 2009;15:153-8 pubmed 出版商
  • 免疫组化; 人类; 1:400
Søiland H, Kørner H, Skaland I, Janssen E, Gudlaugsson E, Varhaug J, et al. Prognostic relevance of androgen receptor detection in operable breast cancer. J Surg Oncol. 2008;98:551-8 pubmed 出版商
  • 免疫组化; 人类; 1:200
Köbel M, Kalloger S, Carrick J, Huntsman D, Asad H, Oliva E, et al. A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary. Am J Surg Pathol. 2009;33:14-21 pubmed 出版商
  • 免疫细胞化学; 人类; 1:25
  • 免疫组化; 人类; 1:200
Fehm T, Krawczyk N, Solomayer E, Becker Pergola G, Dürr Störzer S, Neubauer H, et al. ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients. Breast Cancer Res. 2008;10:R76 pubmed 出版商
  • 免疫组化; 人类
Kefeli M, Yildiz L, Akpolat I, Balci P, Ozen N. The coexistence of invasive ductal carcinoma and malignant phyllodes tumor with liposarcomatous and chondrosarcomatous differentiation in the same breast in a post-osteosarcoma case. Pathol Res Pract. 2008;204:919-23 pubmed 出版商
  • 免疫组化; 人类
Brouckaert O, Pintens S, Van Belle V, Van Huffel S, Camerlynck E, Amant F, et al. Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors. Breast Cancer Res Treat. 2009;115:349-58 pubmed 出版商
  • 免疫组化; 人类; 1:100
Kim S, Seo B, Lee J, Kim S, Cho K, Lee K, et al. Correlation of ultrasound findings with histology, tumor grade, and biological markers in breast cancer. Acta Oncol. 2008;47:1531-8 pubmed 出版商
  • 免疫组化; 人类; 1:300
Rocha R, Nunes C, Rocha G, Oliveira F, Sanches F, Gobbi H. Rabbit monoclonal antibodies show higher sensitivity than mouse monoclonals for estrogen and progesterone receptor evaluation in breast cancer by immunohistochemistry. Pathol Res Pract. 2008;204:655-62 pubmed 出版商
  • 免疫组化; 人类; 1:70
Chen M, Yip G, Tse G, Moriya T, Lui P, Zin M, et al. Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters. Mod Pathol. 2008;21:1183-91 pubmed 出版商
  • 免疫组化; 人类
Neven P, Brouckaert O, Van Belle V, Vanden Bempt I, Hendrickx W, Cho H, et al. In early-stage breast cancer, the estrogen receptor interacts with correlation between human epidermal growth factor receptor 2 status and age at diagnosis, tumor grade, and lymph node involvement. J Clin Oncol. 2008;26:1768-9; author reply 1769-71 pubmed 出版商
  • 免疫组化-石蜡切片; 人类; 1:400; 表 3
  • 免疫组化; 人类; 1:400
Kim T, Huh J, Lee S, Kang H, Kim G, An H. Down-regulation of claudin-2 in breast carcinomas is associated with advanced disease. Histopathology. 2008;53:48-55 pubmed 出版商
  • 免疫组化; 人类; 1:50
Garvin S, Dabrosin C. In vivo measurement of tumor estradiol and vascular endothelial growth factor in breast cancer patients. BMC Cancer. 2008;8:73 pubmed 出版商
  • 免疫组化; 人类
Kaya H, Bozkurt S, Erbarut I, Djamgoz M. Apocrine carcinomas of the breast in Turkish women: hormone receptors, c-erbB-2 and p53 immunoexpression. Pathol Res Pract. 2008;204:367-71 pubmed 出版商
  • 免疫组化; 人类; 1:400
Søiland H, Janssen E, Kørner H, Varhaug J, Skaland I, Gudlaugsson E, et al. Apolipoprotein D predicts adverse outcome in women >or=70 years with operable breast cancer. Breast Cancer Res Treat. 2009;113:519-28 pubmed 出版商
  • 免疫组化; 人类; 1:250
Cheang M, Voduc D, Bajdik C, Leung S, McKinney S, Chia S, et al. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res. 2008;14:1368-76 pubmed 出版商
  • 免疫组化; 人类
Van Calster B, Vanden Bempt I, Drijkoningen M, Pochet N, Cheng J, Van Huffel S, et al. Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive. Breast Cancer Res Treat. 2009;113:181-7 pubmed 出版商
  • 免疫组化; 人类
Tan B, Tan L, Yu K, Tan P, Lee M, Sii L, et al. Clinical validation of a customized multiple signature microarray for breast cancer. Clin Cancer Res. 2008;14:461-9 pubmed 出版商
  • 免疫组化; 人类; 1:250
Crabb S, Bajdik C, Leung S, Speers C, Kennecke H, Huntsman D, et al. Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study. Breast Cancer Res. 2008;10:R6 pubmed 出版商
  • 免疫组化; 人类; 1:100
De Maeyer L, Van Limbergen E, De Nys K, Moerman P, Pochet N, Hendrickx W, et al. Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?. J Clin Oncol. 2008;26:335-6; author reply 336-8 pubmed 出版商
  • 免疫组化; 人类
Bartel F, Jung J, Böhnke A, Gradhand E, Zeng K, Thomssen C, et al. Both germ line and somatic genetics of the p53 pathway affect ovarian cancer incidence and survival. Clin Cancer Res. 2008;14:89-96 pubmed 出版商
  • 免疫组化; 人类; 1:400
Barzon L, Masi G, Pacenti M, Trevisan M, Fallo F, Remo A, et al. Expression of aromatase and estrogen receptors in human adrenocortical tumors. Virchows Arch. 2008;452:181-91 pubmed
  • 免疫组化; 人类; 1:400
Yaren A, Kelten C, Akbulut M, Teke Z, Duzcan E, Erdem E. Primary neuroendocrine carcinoma of the breast: a case report. Tumori. 2007;93:496-8 pubmed
  • 免疫组化; 羊
Gulbahar M, Guvenc T, Yarim M, Kabak Y, Sozgen Y. Mammary fibroadenoma in a lamb. J Vet Sci. 2007;8:423-5 pubmed
  • 免疫组化; 人类; 1:100
Harrell J, Dye W, Harvell D, Pinto M, Jedlicka P, Sartorius C, et al. Estrogen insensitivity in a model of estrogen receptor positive breast cancer lymph node metastasis. Cancer Res. 2007;67:10582-91 pubmed
  • 免疫组化; 人类; 1:400
Savage K, Leung S, Todd S, Brown L, Jones R, Robertson D, et al. Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis. Breast Cancer Res Treat. 2008;110:245-56 pubmed
  • 免疫组化; 人类; 1:250
Turbin D, Leung S, Cheang M, Kennecke H, Montgomery K, McKinney S, et al. Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases. Breast Cancer Res Treat. 2008;110:417-26 pubmed
  • 免疫组化; 人类
Thorat M, Morimiya A, Mehrotra S, Konger R, Badve S. Prostanoid receptor EP1 expression in breast cancer. Mod Pathol. 2008;21:15-21 pubmed
  • 免疫组化; 人类
Eroglu A, Sari A. Expression of c-kit proto-oncogene product in breast cancer tissues. Med Oncol. 2007;24:169-74 pubmed
  • 免疫组化; 人类
Neven P, Van Calster B, Van den Bempt I, Van Huffel S, Van Belle V, Hendrickx W, et al. Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer. Breast Cancer Res Treat. 2008;110:153-9 pubmed
  • 免疫组化; 人类
Badve S, Turbin D, Thorat M, Morimiya A, Nielsen T, Perou C, et al. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival. Clin Cancer Res. 2007;13:4415-21 pubmed
  • 免疫组化; 人类; 1:100
Wong S, Chan J, Lo E, Chan A, Wong M, Chan C, et al. The contribution of bifunctional SkipDewax pretreatment solution, rabbit monoclonal antibodies, and polymer detection systems in immunohistochemistry. Arch Pathol Lab Med. 2007;131:1047-55 pubmed
  • 免疫组化; 人类; 1:150
Giordano G, D Adda T, Gnetti L, Merisio C, Raboni S. Transitional cell carcinoma of the endometrium associated with benign ovarian brenner tumor: a case report with immunohistochemistry molecular analysis and a review of the literature. Int J Gynecol Pathol. 2007;26:298-304 pubmed
  • 免疫细胞化学; 人类; 图 5
  • 免疫组化; 人类
  • 免疫印迹; 人类
Duss S, André S, Nicoulaz A, Fiche M, Bonnefoi H, Brisken C, et al. An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells. Breast Cancer Res. 2007;9:R38 pubmed
  • 免疫组化; 人类; 1:100
Naidu R, Har Y, Taib N. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer. J Exp Clin Cancer Res. 2007;26:133-40 pubmed
  • 免疫印迹; 大鼠
Traish A, Kim S, Stankovic M, Goldstein I, Kim N. Testosterone increases blood flow and expression of androgen and estrogen receptors in the rat vagina. J Sex Med. 2007;4:609-619 pubmed 出版商
  • 免疫组化; 人类; 1:150
Ko S, Na Y, Yoon C, Park J, Kim H, Hur M, et al. The significance of c-erbB-2 overexpression and p53 expression in patients with axillary lymph node--negative breast cancer: a tissue microarray study. Int J Surg Pathol. 2007;15:98-109 pubmed
  • 免疫组化; 人类; 1:150
Decock J, Hendrickx W, Drijkoningen M, Wildiers H, Neven P, Smeets A, et al. Matrix metalloproteinase expression patterns in luminal A type breast carcinomas. Dis Markers. 2007;23:189-96 pubmed
  • 免疫组化; 人类; 1:70
Selvarajan S, Sii L, Lee A, Yip G, Bay B, Tan M, et al. Parafibromin expression in breast cancer: a novel marker for prognostication?. J Clin Pathol. 2008;61:64-7 pubmed
  • 免疫组化; 人类; 1:1000
Tawfik O, Kimler B, Davis M, Stasik C, Lai S, Mayo M, et al. Grading invasive ductal carcinoma of the breast: advantages of using automated proliferation index instead of mitotic count. Virchows Arch. 2007;450:627-36 pubmed
  • 免疫组化; 人类; 1:250
Rajput A, Turbin D, Cheang M, Voduc D, Leung S, Gelmon K, et al. Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases. Breast Cancer Res Treat. 2008;107:249-57 pubmed
  • 免疫组化; 人类; 1:150
Giordano G, D Adda T, Gnetti L, Merisio C, Gabrielli M, Melpignano M. Villoglandular adenocarcinoma of the cervix: two new cases with morphological and molecular study. Int J Gynecol Pathol. 2007;26:199-204 pubmed
  • 免疫组化; 人类
Nadasi E, Anga B, Sandor J, Megyesi J, Kelemen D, Mottolese M, et al. Prognostic factors in Hungarian breast cancer patients. Anticancer Res. 2007;27:279-82 pubmed
  • 免疫印迹; 人类
Rasmussen L, Zaveri N, Stenvang J, Peters R, Lykkesfeldt A. A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer. Breast Cancer Res Treat. 2007;106:191-203 pubmed
  • 免疫组化; 人类; 1:70
Ho B, Tan H, Lee V, Tan P. Preoperative and intraoperative diagnosis of low-grade adenosquamous carcinoma of the breast: potential diagnostic pitfalls. Histopathology. 2006;49:603-11 pubmed
  • 免疫组化; 人类; 1:250
Cheang M, Treaba D, Speers C, Olivotto I, Bajdik C, Chia S, et al. Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival. J Clin Oncol. 2006;24:5637-44 pubmed
  • 免疫组化; 人类; 1:200
Wiseman S, Masoudi H, Niblock P, Turbin D, Rajput A, Hay J, et al. Anaplastic thyroid carcinoma: expression profile of targets for therapy offers new insights for disease treatment. Ann Surg Oncol. 2007;14:719-29 pubmed
  • 免疫组化; 小鼠
Shyamala G, Chou Y, Cardiff R, Vargis E. Effect of c-neu/ ErbB2 expression levels on estrogen receptor alpha-dependent proliferation in mammary epithelial cells: implications for breast cancer biology. Cancer Res. 2006;66:10391-8 pubmed
  • 免疫组化; 人类; 1:100
Lerwill M, Young R. Ovarian metastases of intestinal-type gastric carcinoma: A clinicopathologic study of 4 cases with contrasting features to those of the Krukenberg tumor. Am J Surg Pathol. 2006;30:1382-8 pubmed
  • 免疫组化; 人类; 1:200
Sabah M, Mohan P, Kay E. Para-testicular cellular angiofibroma: a rare tumour in a male renal transplant patient. Virchows Arch. 2006;449:489-92 pubmed
  • 免疫组化; 人类
Hwang C, Park S, Yu S, Park J, Park C, Han K. Hypercalcemia induced by ovarian clear cell carcinoma producing all transcriptional variants of parathyroid hormone-related peptide gene during pregnancy. Gynecol Oncol. 2006;103:740-4 pubmed
  • 免疫印迹; 人类
Juncker Jensen A, Lykkesfeldt A, Worm J, Ralfkiaer U, Espelund U, Jepsen J. Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator. Growth Horm IGF Res. 2006;16:224-39 pubmed
  • 免疫组化; 大鼠; 1:100
Ting A, Kimler B, Fabian C, Petroff B. Characterization of a preclinical model of simultaneous breast and ovarian cancer progression. Carcinogenesis. 2007;28:130-5 pubmed
  • 免疫细胞化学; 小鼠; 1:50
  • 免疫印迹; 小鼠; 1:250
Banerjee N, Genovese N, Noya F, Chien W, Broker T, Chow L. Conditionally activated E7 proteins of high-risk and low-risk human papillomaviruses induce S phase in postmitotic, differentiated human keratinocytes. J Virol. 2006;80:6517-24 pubmed
  • 免疫组化; 人类
Garvin S, Nilsson U, Huss F, Kratz G, Dabrosin C. Estradiol increases VEGF in human breast studied by whole-tissue culture. Cell Tissue Res. 2006;325:245-51 pubmed
  • 免疫组化; 人类; 1:200
Bhandare D, Nayar R, Bryk M, Hou N, Cohn R, Golewale N, et al. Endocrine biomarkers in ductal lavage samples from women at high risk for breast cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:2620-7 pubmed
  • 免疫组化; 人类
Goh B, Tan Y, Kumarasinghe M, Ooi L. Mucinous cystic tumor of the pancreas with ovarian-like mesenchymal stroma in a male patient. Dig Dis Sci. 2005;50:2170-7 pubmed
  • 免疫细胞化学; 人类; 1:100
Lipfert L, Fisher J, Wei N, Scafonas A, Su Q, Yudkovitz J, et al. Antagonist-induced, activation function-2-independent estrogen receptor alpha phosphorylation. Mol Endocrinol. 2006;20:516-33 pubmed
  • 免疫组化; 人类; 1:100
Kurita T, Medina R, Schabel A, Young P, Gama P, Parekh T, et al. The activation function-1 domain of estrogen receptor alpha in uterine stromal cells is required for mouse but not human uterine epithelial response to estrogen. Differentiation. 2005;73:313-22 pubmed
  • 免疫组化; 人类; 1:20
Matos I, Dufloth R, Alvarenga M, Zeferino L, Schmitt F. p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas. Virchows Arch. 2005;447:688-94 pubmed
  • 免疫组化; 人类
Hascalik S, Celik O, Erdem G, Usta U, Alkan A, Karakas H, et al. Synchronous endometrial and cervical tumors in a 26-year-old nullipara: diagnostic modalities updated. Gynecol Obstet Invest. 2005;60:171-6 pubmed
  • 免疫印迹; 人类; 1:10000
Sonne Hansen K, Lykkesfeldt A. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line. J Steroid Biochem Mol Biol. 2005;93:25-34 pubmed
  • 免疫组化; 人类; 1:150
Giordano G, D Adda T, Merisio C, Gnetti L. Primary squamous cell carcinoma of the endometrium: a case report with immunohistochemical and molecular study. Gynecol Oncol. 2005;96:876-9 pubmed
Kubyshkin A, Aliev L, Fomochkina I, Kovalenko Y, Litvinova S, Filonenko T, et al. Endometrial hyperplasia-related inflammation: its role in the development and progression of endometrial hyperplasia. Inflamm Res. 2016;65:785-94 pubmed 出版商
Al Harras M, Houssen M, Shaker M, Farag K, Farouk O, Monir R, et al. Polymorphisms of glutathione S-transferase ? 1 and toll-like receptors 2 and 9: Association with breast cancer susceptibility. Oncol Lett. 2016;11:2182-2188 pubmed
Parra Herran C, Schoolmeester J, Yuan L, Dal Cin P, Fletcher C, Quade B, et al. Myxoid Leiomyosarcoma of the Uterus: A Clinicopathologic Analysis of 30 Cases and Review of the Literature With Reappraisal of Its Distinction From Other Uterine Myxoid Mesenchymal Neoplasms. Am J Surg Pathol. 2016;40:285-301 pubmed 出版商
Haldorsen I, Popa M, Fonnes T, Brekke N, Kopperud R, Visser N, et al. Multimodal Imaging of Orthotopic Mouse Model of Endometrial Carcinoma. PLoS ONE. 2015;10:e0135220 pubmed 出版商
Marsden C, Wright M, Carrier L, Moroz K, Pochampally R, Rowan B. "A novel in vivo model for the study of human breast cancer metastasis using primary breast tumor-initiating cells from patient biopsies". BMC Cancer. 2012;12:10 pubmed 出版商
Burch D, Tavassoli F. Myxoid leiomyosarcoma of the uterus. Histopathology. 2011;59:1144-55 pubmed 出版商
Park S, Kwon H, Choi Y, Lee H, Kim S, Kim J, et al. Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes. Mod Pathol. 2012;25:185-96 pubmed 出版商
Chaban V, Lakhter A, Micevych P. A membrane estrogen receptor mediates intracellular calcium release in astrocytes. Endocrinology. 2004;145:3788-95 pubmed
产品信息
产品类型 :
抗体
产品名称 :
雌激素受体α单克隆抗体(Sp1转录因子)
目录# :
MA1-39539
规格 :
7毫升
价格 :
美国349.00
克隆性 :
单克隆
宿主 :
反应物种 :
人类
应用 :
Immunohistochemistry (Paraffin): Ready-to-use
物种 :
人类
克隆 :
Sp1转录因子
抗体亚型 :
IgG
储存 :
4° C, 不冻结
描述 :
Estrogen Receptors (ER) are members of the steroid/thyroid hormone receptor superfamily of nuclear receptors. The estrogen receptor is a ligand-activated transcription factor, that when bound to estrogen hormone, induces a conformational change that allows dimerization and binding to estrogen response elements (ERE) in DNA. When bound to EREs, ER can positively or negatively regulate gene transcription through the recruitment of coactivator or corepressor proteins. There are two different forms of the estrogen receptor, alpha and beta, encoded by separate genes (ESR1 and ESR2, respectively). Due to alternative RNA splicing, at least 4 estrogen receptor-alpha isoforms are known to exist (Isoform 1 (66 kDa), Isoform 2 (53 kDa), Isoform 3 (47 kDa), Isoform 4 (35 kDa)). Estrogen receptors are widely expressed in different tissue types and are essential for sexual development and reproductive function. They also play a role in other tissues such as bone. Estrogen receptors are involved in pathological processes including breast cancer, endometrial cancer, and osteoporosis.
免疫原 :
Synthetic peptide derived from C-terminus of human estrogen receptor alpha
格式 :
Liquid
应用w/稀释 :
Immunohistochemistry (Paraffin): Ready-to-use
别名 :
RP1-130E4.1, DKFZp686N23123, ER, ESR, ESRA, Era, NR3A1
更多信息或购买 :
公司信息
赛默飞世尔
上海浦东新金桥路27号7号楼
analyze.cn@thermofisher.com
www.thermo.com.cn
1084193588
公司总部: 美国